Personalized feedback to reduce hazardous drinking in Hispanic adults with anxiety
Hispanic Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
A brief computer program giving personalized feedback to help Hispanic adults who drink hazardously and have clinical anxiety cut down on alcohol use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11113822 on NIH RePORTER |
What this research studies
You would use a short, single-session computer program that gives personalized feedback about how anxiety and drinking affect each other. The team will refine the program using feedback from small focus groups of Hispanic adults to make sure the content feels relevant and acceptable. After that, people will be randomly assigned to the new anxiety-focused feedback program or to a control version and followed through community health clinics. The goal is to see whether the tailored feedback increases motivation to reduce drinking and lowers use of alcohol to cope with anxiety.
Who could benefit from this research
Good fit: Hispanic adults who currently drink at hazardous levels and meet criteria for clinical anxiety, and who can attend participating community health clinics, are the ideal candidates.
Not a fit: People who do not drink hazardously, do not have clinical anxiety, are not Hispanic (for this tailored intervention), or cannot use a computer-based program are unlikely to benefit from this specific intervention.
Why it matters
Potential benefit: If successful, this could provide a low-cost, easy-to-deliver option to help Hispanic patients reduce hazardous drinking and improve anxiety-related coping.
How similar studies have performed: Brief personalized feedback programs have reduced drinking in other populations, but an anxiety-integrated, Hispanic-tailored version like this is novel and less tested.
Where this research is happening
Houston, United States
- University of Houston — Houston, United States (Active)
Researchers
- Principal investigator: Zvolensky, Michael J. — University of Houston
- Study coordinator: Zvolensky, Michael J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.